Kawasaki disease: Who is at risk?

Journal of Pediatrics

Volumn 137, Issue 2, 2000, Pages 149-152

  Newburger, Jane W ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN;

CLINICAL FEATURE; CLINICAL PROTOCOL; CORONARY ARTERY ANEURYSM; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; EDITORIAL; HUMAN; LABORATORY TEST; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RISK; VASCULITIS;

EID: 0033837727     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.109025     Document Type: Article

References (32)

1. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children
2. Seven-year national survey of Kawasaki disease and acute rheumatic fever
3. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
4. The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment
5. Diagnosis and therapy of Kawasaki disease in children
6. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease
7. Incomplete Kawasaki disease with coronary artery involvement
8. Kawasaki disease: More patients are being diagnosed who do not meet American Heart Association criteria
9. Summary and abstracts of the Sixth International Kawasaki Disease Symposium
10. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age
11. Kawasaki disease in older children and adolescents
12. Recognition and management of Kawasaki disease
13. Kawasaki disease in the older child
14. Cardiac sequelae of Kawasaki disease in Japan over 10 years
15. Diagnosis and therapy of Kawasaki disease in children
16. Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of artery aneurysms
17. Cerebrospinal fluid profile in patients with acute Kawasaki disease
18. Intravenous gamma globulin treatment and retreatment in Kawasaki disease
19. Treatment of Kawasaki disease: Corticosteroids revisited
20. Gamma-globulin retreatment in Kawasaki disease
21. Immunoregulation and pentoxifylline therapy during acute Kawasaki disease
22. Trial of prevention of coronary aneurysm in Kawasaki's using plasma exchange or infusion of immunoglobulins
23. Prediction of non-responsiveness to intravenous high-dose γ-globulin therapy in patients with Kawasaki disease at onset
24. Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease
25. Diagnosis and prognosis of coronary artery lesions in Kawasaki disease, Coronary angiography and the conditions for its application (a score chart)
26. Kawasaki disease: Review of risk factors for coronary aneurysms
27. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: Risk factors and role of aspirin
28. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease
29. Predictive factors of coronary aneurysm in Kawasaki disease - Correlation between coronary arterial lesions and serum albumin, cholinesterase activity, prealbumin, retinol-binding protein and immature neutrophils
30. The treatment of Kawasaki syndrome with intravenous gamma globulin
31. Indication for intravenous gamma globulin treatment for Kawasaki disease
32. A predictive instrument for coronary artery aneurysms in Kawasaki disease